SEARCH

SEARCH BY CITATION

References

  • 1
    The Organ Procurement and Transplantation Network. Available at: http://optn.transplant.hrsa.gov/ Accessed November 15, 2012.
  • 2
    Franklin GA, Santos AP, Smith JW, et al. Optimization of donor management goals yields increased organ use. Am Surg; 76: 587594.
  • 3
    Hagan ME, McClean D, Falcone CA, et al. Attaining specific donor management goals increases number of organs transplanted per donor: A quality improvement project. Prog Transplant 2009; 19: 227231.
  • 4
    Malinoski DJ, Daly MC, Patel MS, et al. Achieving donor management goals before deceased donor procurement is associated with more organs transplanted per donor. J Trauma 2011; 71: 990995; discussion 996.
  • 5
    Malinoski DJ, Patel MS, Daly MC, et al. The impact of meeting donor management goals on the number of organs transplanted per donor: Results from the United Network for Organ Sharing Region 5 prospective donor management goals study. Crit Care Med 2012; 40: 27732780.
  • 6
    Merchant SJ, Yoshida EM, Lee TK, et al. Exploring the psychological effects of deceased organ donation on the families of the organ donors. Clin Transplant 2008; 22: 341347.
  • 7
    Koning OH, Ploeg RJ, van Bockel JH, et al. Risk factors for delayed graft function in cadaveric kidney transplantation: A prospective study of renal function and graft survival after preservation with University of Wisconsin solution in multi-organ donors. European Multicenter Study Group. Transplantation 1997; 63: 16201628.
  • 8
    Perico N, Cattaneo D, Sayegh MH, et al. Delayed graft function in kidney transplantation. Lancet 2004; 364: 18141827.
  • 9
    Peeters P, Terryn W, Vanholder R, et al. Delayed graft function in renal transplantation. Curr Opin Crit Care 2004; 10: 489498.
  • 10
    Moers C, Smits JM, Maathuis MH, et al. Machine perfusion or cold storage in deceased-donor kidney transplantation. N Engl J Med 2009; 360: 719.
  • 11
    Schnuelle P, Gottmann U, Hoeger S, et al. Effects of donor pretreatment with dopamine on graft function after kidney transplantation: A randomized controlled trial. JAMA 2009; 302: 10671075.
  • 12
    Shemie SD, Ross H, Pagliarello J, et al. Organ donor management in Canada: Recommendations of the forum on Medical Management to Optimize Donor Organ Potential. CMAJ 2006; 174: S13S32.
  • 13
    United Network for Organ Sharing- Clinical Pathway for the Organ Donor 2002, 2001, 1998. Available at: http://www.unos.org/donation/index.php?topic=best_practices. Accessed May 6, 2011.
  • 14
    Schnuelle P, Berger S, de Boer J, et al. Effects of catecholamine application to brain-dead donors on graft survival in solid organ transplantation. Transplantation 2001; 72: 455463.
  • 15
    Blasi-Ibanez A, Hirose R, Feiner J, et al. Predictors associated with terminal renal function in deceased organ donors in the intensive care unit. Anesthesiology 2009; 110: 333341.
  • 16
    Blasco V, Leone M, Bouvenot J, et al. Impact of intensive care on renal function before graft harvest: Results of a monocentric study. Crit Care 2007; 11: R103.
  • 17
    Blasco V, Leone M, Antonini F, et al. Comparison of the novel hydroxyethylstarch 130/0.4 and hydroxyethylstarch 200/0.6 in brain-dead donor resuscitation on renal function after transplantation. Br J Anaesth 2008; 100: 504508.
  • 18
    Darby JM, Stein K, Grenvik A, et al. Approach to management of the heartbeating “brain dead” organ donor. JAMA 1989; 261: 22222228.
  • 19
    Giral M, Bertola JP, Foucher Y, et al. Effect of brain-dead donor resuscitation on delayed graft function: results of a monocentric analysis. Transplantation 2007; 83: 11741181.
  • 20
    Deman A, Peeters P, Sennesael J. Hydroxyethyl starch does not impair immediate renal function in kidney transplant recipients: A retrospective, multicentre analysis. Nephrol Dial Transplant 1999; 14: 15171520.
  • 21
    Cittanova ML, Mavre J, Riou B, et al. Long-term follow-up of transplanted kidneys according to plasma volume expander of kidney donors. Intensive Care Med 2001; 27: 1830.
  • 22
    Shen GK, Recicar JF, Hovsepian RV, et al. Correction of base deficits in deceased organ donors: Effects on immediate renal allograft function. Transplant Proc 2004; 36: 25592561.
  • 23
    Finfer S, Bohn D, Colpitts D, et al. Intensive care management of paediatric organ donors and its effect on posttransplant organ function. Intensive Care Med 1996; 22: 14241432.
  • 24
    Canivet JL, Damas P, Hans P, et al. Fluid management and plasma renin activity in organ donors. Transpl Int 1989; 2: 129132.
  • 25
    Premasathian N, Avihingsanon Y, Ingsathit A, et al. Risk factors and outcome of delayed graft function after cadaveric kidney transplantation: A report from the Thai Transplant Registry. Transplant Proc 2010; 42: 40174020.
  • 26
    Boom H, Mallat MJ, de Fijter JW, et al. Delayed graft function influences renal function, but not survival. Kidney Int 2000; 58: 859866.
  • 27
    Johnson CP, Kuhn EM, Hariharan S, et al. Pre-transplant identification of risk factors that adversely affect length of stay and charges for renal transplantation. Clin Transplant 1999; 13: 168175.
  • 28
    Malinoski DJ, Patel MS, Lush S, et al. Impact of compliance with the American College of Surgeons trauma center verification requirements on organ donation-related outcomes. J Am College Surg 2012; 215: 186192.